454 related articles for article (PubMed ID: 31881872)
1. Non-invasive skin autofluorescence, blood and urine assays of the advanced glycation end product (AGE) pentosidine as an indirect indicator of AGE content in human bone.
Kida Y; Saito M; Shinohara A; Soshi S; Marumo K
BMC Musculoskelet Disord; 2019 Dec; 20(1):627. PubMed ID: 31881872
[TBL] [Abstract][Full Text] [Related]
2. Differences in non-enzymatic glycation and collagen cross-links between human cortical and cancellous bone.
Karim L; Tang SY; Sroga GE; Vashishth D
Osteoporos Int; 2013 Sep; 24(9):2441-7. PubMed ID: 23471564
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of carboxymethyl-lysine (CML) in human cortical bone.
Thomas CJ; Cleland TP; Sroga GE; Vashishth D
Bone; 2018 May; 110():128-133. PubMed ID: 29408699
[TBL] [Abstract][Full Text] [Related]
4. Nonenzymatic cross-linking pentosidine increase in bone collagen and are associated with disorders of bone mineralization in dialysis patients.
Mitome J; Yamamoto H; Saito M; Yokoyama K; Marumo K; Hosoya T
Calcif Tissue Int; 2011 Jun; 88(6):521-9. PubMed ID: 21499867
[TBL] [Abstract][Full Text] [Related]
5. High serum pentosidine but not esRAGE is associated with prevalent fractures in type 1 diabetes independent of bone mineral density and glycaemic control.
Neumann T; Lodes S; Kästner B; Franke S; Kiehntopf M; Lehmann T; Müller UA; Wolf G; Sämann A
Osteoporos Int; 2014 May; 25(5):1527-33. PubMed ID: 24599273
[TBL] [Abstract][Full Text] [Related]
6. Skin Autofluorescence, a Noninvasive Biomarker for Advanced Glycation End-Products, Is Associated With Prevalent Vertebral and Major Osteoporotic Fractures: The Rotterdam Study.
Waqas K; Chen J; Koromani F; Trajanoska K; van der Eerden BC; Uitterlinden AG; Rivadeneira F; Zillikens MC
J Bone Miner Res; 2020 Oct; 35(10):1904-1913. PubMed ID: 32463533
[TBL] [Abstract][Full Text] [Related]
7. Ratio of Endogenous Secretory Receptor for Advanced Glycation End Products to Pentosidine Predicts Fractures in Men.
Tamaki J; Kouda K; Fujita Y; Iki M; Yura A; Miura M; Sato Y; Okamoto N; Kurumatani N
J Clin Endocrinol Metab; 2018 Jan; 103(1):85-94. PubMed ID: 29040721
[TBL] [Abstract][Full Text] [Related]
8. [Roles of collagen enzymatic and advanced glycation end products associated crosslinking as a determinant of bone quality].
Saito M; Marumo K
Nihon Rinsho; 2011 Jul; 69(7):1189-97. PubMed ID: 21774356
[TBL] [Abstract][Full Text] [Related]
9. Disparate changes in plasma and tissue pentosidine levels after kidney and kidney-pancreas transplantation.
Hricik DE; Wu YC; Schulak A; Friedlander MA
Clin Transplant; 1996 Dec; 10(6 Pt 1):568-73. PubMed ID: 8996781
[TBL] [Abstract][Full Text] [Related]
10. Urinary Pentosidine levels negatively associates with trabecular bone scores in patients with type 2 diabetes mellitus.
Choi YJ; Ock SY; Jin Y; Lee JS; Kim SH; Chung Y-
Osteoporos Int; 2018 Apr; 29(4):907-915. PubMed ID: 29322222
[TBL] [Abstract][Full Text] [Related]
11. [Biochemical markers of bone turnover. New aspect. Bone collagen metabolism: new biological markers for estimation of bone quality].
Saito M
Clin Calcium; 2009 Aug; 19(8):1110-7. PubMed ID: 19638694
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products and bone loss during aging.
Odetti P; Rossi S; Monacelli F; Poggi A; Cirnigliaro M; Federici M; Federici A
Ann N Y Acad Sci; 2005 Jun; 1043():710-7. PubMed ID: 16037297
[TBL] [Abstract][Full Text] [Related]
13. Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae.
Viguet-Carrin S; Roux JP; Arlot ME; Merabet Z; Leeming DJ; Byrjalsen I; Delmas PD; Bouxsein ML
Bone; 2006 Nov; 39(5):1073-1079. PubMed ID: 16829221
[TBL] [Abstract][Full Text] [Related]
14. Two fluorescent wavelengths, 440(ex)/520(em) nm and 370(ex)/440(em) nm, reflect advanced glycation and oxidation end products in human skin without diabetes.
Beisswenger PJ; Howell S; Mackenzie T; Corstjens H; Muizzuddin N; Matsui MS
Diabetes Technol Ther; 2012 Mar; 14(3):285-92. PubMed ID: 22023375
[TBL] [Abstract][Full Text] [Related]
15. Skin collagen pentosidine and fluorescence in diabetes were predictors of retinopathy progression and creatininemia increase already 6years after punch-biopsy.
Sternberg M; M'bemba J; Urios P; Borsos AM; Selam JL; Peyroux J; Slama G
Clin Biochem; 2016 Feb; 49(3):225-31. PubMed ID: 26506116
[TBL] [Abstract][Full Text] [Related]
16. Effects of 18-month treatment with bazedoxifene on enzymatic immature and mature cross-links and non-enzymatic advanced glycation end products, mineralization, and trabecular microarchitecture of vertebra in ovariectomized monkeys.
Saito M; Kida Y; Nishizawa T; Arakawa S; Okabe H; Seki A; Marumo K
Bone; 2015 Dec; 81():573-580. PubMed ID: 26385255
[TBL] [Abstract][Full Text] [Related]
17. Age-related accumulation of Maillard reaction products in human articular cartilage collagen.
Verzijl N; DeGroot J; Oldehinkel E; Bank RA; Thorpe SR; Baynes JW; Bayliss MT; Bijlsma JW; Lafeber FP; Tekoppele JM
Biochem J; 2000 Sep; 350 Pt 2(Pt 2):381-7. PubMed ID: 10947951
[TBL] [Abstract][Full Text] [Related]
18. Age-related increase in an advanced glycation end product in penile tissue.
Jiaan DB; Seftel AD; Fogarty J; Hampel N; Cruz W; Pomerantz J; Zuik M; Monnier VM
World J Urol; 1995; 13(6):369-75. PubMed ID: 9116757
[TBL] [Abstract][Full Text] [Related]
19. Pentosidine and carboxymethyl-lysine associate differently with prevalent osteoporotic vertebral fracture and various bone markers.
Nakano M; Nakamura Y; Suzuki T; Miyazaki A; Takahashi J; Saito M; Shiraki M
Sci Rep; 2020 Dec; 10(1):22090. PubMed ID: 33328494
[TBL] [Abstract][Full Text] [Related]
20. The association of urinary pentosidine levels with the prevalence of osteoporotic fractures in postmenopausal women.
Shiraki M; Kashiwabara S; Imai T; Tanaka S; Saito M
J Bone Miner Metab; 2019 Nov; 37(6):1067-1074. PubMed ID: 31214839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
